SKC will take part at ISPOR Europe 2018 with seven exciting poster presentations
Apart from three huge thought-provoking plenary sessions, more than 2,500 presentations and short courses will take place. We are proud that we will be actively participating with seven submitted abstracts and corresponding poster presentations. With our ideas and analyses, we want to contribute to the development of future health care.
Meet us at the ISPOR and discuss the following prospective topics with us:
Monday, 12th of November, 12:45 to 1:45 PM:
Tuesday, 13th of November, 12:30 to 1:30 PM:
- Enzyme replacement therapies within the German HTA (AMNOG) process (PHP 38)
- Impact of dynamic changes of the definition of the appropriate comparative therapy (ACT) on market access performance of new active substances in Germany (PHP261)
- Orphan drugs’ market access challenges in Europe from a German perspective (PHP 325)
- Orphan drugs in Germany – lessons learned from AMNOG, best and worst practices and strategic implications (PHP 293)
- German early benefit assessments of orphan drugs under full dossier conditions (PHP 287)
Wednesday, 14th of November, 12:15 to 1:15 PM:
We are the leading strategy consultancy in the German health care sector. Our expertise covers the branches pharmaceutical industry, med- and biotechnology, health insurances and the trending topic digital health. We are looking forward to an inspiring ISPOR event in Barcelona and especially to exciting discussions with you.
Please find more information at https://www.ispor.org/conferences-education/conferences/upcoming-conferences/europe-2018